Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW.

Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.

PMID:
21144578
2.

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.

Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL.

Am J Epidemiol. 2010 Sep 1;172(5):578-90. doi: 10.1093/aje/kwq175. Epub 2010 Aug 5.

3.

Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.

Bradley MC, Hughes CM, Cantwell MM, Napolitano G, Murray LJ.

Br J Cancer. 2010 Apr 27;102(9):1415-21. doi: 10.1038/sj.bjc.6605636. Epub 2010 Apr 6.

4.

Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study.

Prizment AE, Folsom AR, Anderson KE.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):435-42. doi: 10.1158/1055-9965.EPI-09-0976.

5.
6.

Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.

Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE.

Cancer Res. 2008 Apr 1;68(7):2507-13. doi: 10.1158/0008-5472.CAN-07-6257.

7.

Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories.

Capurso G, Sch√ľnemann HJ, Terrenato I, Moretti A, Koch M, Muti P, Capurso L, Delle Fave G.

Aliment Pharmacol Ther. 2007 Oct 15;26(8):1089-99. Review.

8.

Mitochondrial genetic polymorphisms and pancreatic cancer risk.

Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1455-9.

9.

Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?

Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.

Pharmacogenet Genomics. 2007 Aug;17(8):639-45.

PMID:
17622940
10.

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.

PMID:
17551148
11.

Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.

Larsson SC, Giovannucci E, Bergkvist L, Wolk A.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2561-4.

12.

Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.

Mahipal A, Anderson KE, Limburg PJ, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1785-90.

13.

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.

Ulrich CM, Bigler J, Potter JD.

Nat Rev Cancer. 2006 Feb;6(2):130-40. Review.

PMID:
16491072
14.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

15.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

PMID:
15998950
16.

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):47-55.

PMID:
15998890
17.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

PMID:
15928301
18.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

19.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

20.

COX-3 and the mechanism of action of paracetamol/acetaminophen.

Botting R, Ayoub SS.

Prostaglandins Leukot Essent Fatty Acids. 2005 Feb;72(2):85-7. Review.

PMID:
15626590

Supplemental Content

Support Center